Projects per year
- 1 - 50 out of 510 results
Search results
-
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
5/1/19 → 4/30/24
Project: Federal Funding Agencies
-
Multi-arm Optimization of Stroke Thrombolysis (MOST): a blinded, randomized controlled adaptive, multi-arm, adjunctive-thrombolysis efficacy trial in ischemic stroke.
6/1/18 → 4/30/24
Project: Federal Funding Agencies
-
Multi-arm Optimization of Stroke Thrombolysis (MOST): a blinded, randomized controlled adaptive, multi-arm, adjunctive-thrombolysis efficacy trial in ischemic stroke.
6/1/18 → 4/30/24
Project: Federal Funding Agencies
-
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
6/1/19 → 4/30/24
Project: Federal Funding Agencies
-
A structure-based machine learning framework to engineer antibody stability maturation and affinity
1/3/22 → 4/30/24
Project: Federal Funding Agencies
-
African trypanosome parasites: a new tool to unveil potential immunological strategies totarget CLL
5/3/21 → 4/30/24
Project: Federal Funding Agencies
-
VENOUS ETHANOL ABLATION IN ISCHEMIC VENTRICULAR TACHYCARDIA- VELVET TRIAL
5/1/23 → 4/30/24
Project: Federal Funding Agencies
-
Predictive Analytics in Hemodialysis: Enabling Precision Care for Patient with ESKD
10/22/22 → 4/30/24
Project: Federal Funding Agencies
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/24
Project: Federal Funding Agencies
-
The immunosuppressive function of secretory IgM in tumor-bearing mice
6/1/21 → 5/31/24
Project: Federal Funding Agencies
-
Novel Therapeutic Strategies to Co-Target AR+ and AR-/lo Prostate Cancer Cells
6/1/19 → 5/31/24
Project: Federal Funding Agencies
-
AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)
Masdeu, J. C., Toledo, J. B., Faridar, A. & Nakawah, M. O.
9/30/19 → 5/31/24
Project: Federal Funding Agencies
-
LONGITUDINAL EARLY ONSET ALZHEIMERâ??S DISEASE (LEADS)
Masdeu, J. C., Faridar, A., Nakawah, M. O. & Pascual, B.
9/15/17 → 5/31/24
Project: Non Profit
-
Longitudinal multi-center head-to-head harmonization of tau PET tracers
9/1/21 → 5/31/24
Project: Federal Funding Agencies
-
LONGITUDINAL EARLY ONSET ALZHEIMER¿S DISEASE (LEADS) supplement
6/1/20 → 5/31/24
Project: Federal Funding Agencies
-
Hes1-loss promotes dysregulation of epithelial homeostasis and inflammation in a serrated adenocarcinoma model
6/24/23 → 5/31/24
Project: Federal Funding Agencies
-
Metabolomics of Uremic Symptoms in Dialysis Patients
10/24/22 → 5/31/24
Project: Federal Funding Agencies
-
A multi-center, randomized, 36-month, parallel group, non-inferiority, phase III study to compare the effectiveness of 500 mcg QD or alternate regimen of roflumilast (Daliresp) therapy versus 250 mg QD, 500 mg QD three times per week, or alternate regime
12/1/21 → 5/31/24
Project: Federal Funding Agencies
-
-
Systematic Alzheimer's disease drug repositioning (SMART) based on bioinformatics-guided phenotype screening and image-omics
9/15/18 → 5/31/24
Project: Federal Funding Agencies
-
Physiologically Based Pharmacokinetic Modeling of Silica Nanoparticles
9/6/22 → 6/30/24
Project: Federal Funding Agencies
-
-
Genetic mechanism of conserved ancestral haplotype in SCA10
2/1/19 → 6/30/24
Project: Federal Funding Agencies
-
Learning-Based Approach for Personalized Craniomaxillofacial Surgical Planning
Gateno, J., Alfi, D. & Fung, S. H.
7/1/17 → 6/30/24
Project: Federal Funding Agencies
-
-
-
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) - Clinical Core
9/15/19 → 6/30/24
Project: Federal Funding Agencies
-
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Pascual, B., Faridar, A. & Masdeu, J. C.
9/15/19 → 6/30/24
Project: Non Profit
-
The LiaFSR system and antimicrobial peptide resistance in enterococci
2/1/22 → 6/30/24
Project: Federal Funding Agencies
-
Engineered Enteric Nervous System-Peri Neural Invasion platform to improve predictive preclinical screens in early-stage colorectal adenocarcinomas
7/1/21 → 6/30/24
Project: Federal Funding Agencies
-
Long non-coding RNA mediated chromatin remodeling in angiogenesis
7/1/19 → 6/30/24
Project: Federal Funding Agencies
-
Self-assembled multifunctional aptamer-complex biomaterial for precision medicine
1/15/18 → 6/30/24
Project: Federal Funding Agencies
-
-
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy
7/15/21 → 6/30/24
Project: Federal Funding Agencies
-
Emergence of TonB-dependent receptor mediated cefiderocol resistance among multidrugresistant (MDR) Pseudomonas aeruginosa clinical isolates
7/1/22 → 6/30/24
Project: Federal Funding Agencies
-
Investigation of novel local immunomodulating strategies to enhance islet transplantation for T1D
7/1/22 → 6/30/24
Project: Non Profit
-
Methods and devices to assist and improve cerebrospinal fluid drainage
7/1/22 → 6/30/24
Project: Federal Funding Agencies
-
RISK STRATIFICATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS WITHIN THE HOUSTON METHODIST HOSPITAL CLINICAL NETWORK
1/1/21 → 7/14/24
Project: Non Profit
-
-
Non-invasive spinal neuromodulation and robotic exoskeleton to recover upper limb function after SCI
Sayenko, D., Horner, P. J. & Kaldis, T.
7/31/21 → 7/30/24
Project: Non Profit
-
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
8/1/19 → 7/31/24
Project: Federal Funding Agencies
-
Integrating in vivo and in silico models of prostate cancer-bone metastasis to overcome anti-tumor therapy resistance
8/1/22 → 7/31/24
Project: Federal Funding Agencies
-
-
Transforming triple negative breast cancer treatment through intratumoral immunotherapy via nanofluidic drug eluting seed
8/1/20 → 7/31/24
Project: Federal Funding Agencies
-
MRI Based Calf Muscle Perfusion To Assess Patients with Symptomatic PAD
Bismuth, J. & Shah, D. J.
8/19/19 → 7/31/24
Project: Federal Funding Agencies
-
Transforming triple negative breast cancer treatment through intratumoral immunotherapy via nanofluidic drug eluting seed
8/1/20 → 7/31/24
Project: Federal Funding Agencies
-
Prevascularized encapsulation platform with local immunosuppression for Islet transplantation
8/1/21 → 7/31/24
Project: Non Profit
-
Longitudinal Characteristics of the Gut, Bladder, and Vaginal Microbiomes in Postmenopausal Women with Recurrent Urinary Tract Infections
8/1/23 → 7/31/24
Project: Non Profit